The international Journal Synergy is dedicated to the understanding, development and application of the principles of “Synergy” in life science.
Multimodal treatments or multitarget approaches are increasingly applied to treat complex diseases in different disciplines of medicine - mainly based on empirical knowledge. There is a need to elucidate further the combinatory actions in the context of synergy, including the prevention of potential adverse events.
The journal Synergy is published to act as the international platform and source for the dissemination, exchange and discourse of innovative research on the systematic development of combination therapies based on synergistic effects and the rationali-sation of synergistic and antagonistic modes of action. Preclinical and clinical research results are invited from the fields of medicine, molecular and cellular biology, toxicology, pharmacology, pharmacy, and bioinformatics.
Synergy encourages research on combinations of single and multicomponent drugs of synthetic or of natural origin as well as multidisciplinary and multicultural research. It promotes the application of “Omic”- technologies in addition to conventional methods which increasingly allow the understanding of complex disease traits and bring them into the context of system biology.
Synergy is published by ELSEVIER, a world-leading provider of scientific, technical and medical information products and services. The editor-in-chief is Gudrun Ulrich-Merzenich (Bonn), the co-editor is Ting-Chao Chou (New York).
Synergy welcomes relevant contributions in the forms of original research papers, reviews, rapid communications, perspectives and letters to the editor. Commentaries are by invitation only.
Synergy will issue a special edition at the occasion of the Synergy Forum 2018.
For more information and access to current articles please visit the journal website